Pickkers, Peter http://orcid.org/0000-0002-1104-4303
Darmon, Michael http://orcid.org/0000-0003-4198-8038
Hoste, Eric http://orcid.org/0000-0001-9301-8055
Joannidis, Michael
Legrand, Matthieu http://orcid.org/0000-0001-9788-5316
Ostermann, Marlies http://orcid.org/0000-0001-9500-9080
Prowle, John R. http://orcid.org/0000-0002-5002-2721
Schneider, Antoine http://orcid.org/0000-0003-0576-7094
Schetz, Miet http://orcid.org/0000-0001-5776-4827
Article History
Received: 2 March 2021
Accepted: 4 June 2021
First Online: 2 July 2021
Declarations
:
: PP declares having received speaker fees from Baxter and consultancy fees from AM-Pharma. MD declares having received speaker fees from Astelas, Gilead-Kite and MSD along with a grant from MSD outside the scope of this manuscript. EH declares speaker fees from Alexion and Sopachem (paid to the university), travel grant from AM-Pharma. MJ has received honoraria and research support from Baxter Healthcare Corp, AM-Pharma, CLS Behring, Fresenius, and Astute Medical. ML declares no conflict of interest. MO declares speaker fees from Fresenius and Biomerieux, research funding from Baxter, Biomerieux and LaJolla Pharma and consultancy fee from NxStage. JRP has received grant and/or research support from bioMérieux, consulting fees from Medibeacon Inc., Beckton Dickinson Inc and Jafron Biomedical Co Ltd and speaker’s honoraria from Nikkiso Europe GmbH, Baxter, Braun Medical Ltd, Fresenius Medical Care and Fresenius-Kabi UK. AS has received a grant from the Leenaards foundation, speaker honoraria from Fresenius Medical Care and consulting honoraria from B Braun Melsungen AG. MS has no conflict of interest to declare.